These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29241665)

  • 1. Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients.
    Zhao J; Zhang B; Zhu J; Nussinov R; Ma B
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2294-2303. PubMed ID: 29241665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.
    Brumshtein B; Esswein SR; Sawaya MR; Rosenberg G; Ly AT; Landau M; Eisenberg DS
    J Biol Chem; 2018 Dec; 293(51):19659-19671. PubMed ID: 30355736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.
    Hernández-Santoyo A; del Pozo Yauner L; Fuentes-Silva D; Ortiz E; Rudiño-Piñera E; Sánchez-López R; Horjales E; Becerril B; Rodríguez-Romero A
    J Mol Biol; 2010 Feb; 396(2):280-92. PubMed ID: 19941869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.
    Goldis R; Kaplan B; Arad M; Dispenzieri A; Dasari S; Kukuy OL; Simon AJ; Dori A; Shavit-Stein E; Ziv T; Murray D; Kourelis T; Gertz MA; Dominissini D; Magen H; Muchtar E
    Clin Chem Lab Med; 2024 Feb; 62(3):464-471. PubMed ID: 37747270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis.
    Brancaccio D; Ghiggeri GM; Braidotti P; Garberi A; Gallieni M; Bellotti V; Zoni U; Gusmano R; Coggi G
    J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between κ and λ light chain amyloidosis analyzed by a pathologic scoring system.
    Wu H; L'Imperio V; Rossi M; Kapp ME; Paueksakon P
    Am J Clin Pathol; 2023 Aug; 160(2):144-149. PubMed ID: 36933186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability.
    Pradhan T; Annamalai K; Sarkar R; Huhn S; Hegenbart U; Schönland S; Fändrich M; Reif B
    J Biol Chem; 2020 Dec; 295(52):18474-18484. PubMed ID: 33093170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound screening identified gossypetin and isoquercitrin as novel inhibitors for amyloid fibril formations of Vλ6 proteins associated with AL amyloidosis.
    Takahashi D; Matsunaga E; Yamashita T; Caaveiro JMM; Abe Y; Ueda T
    Biochem Biophys Res Commun; 2022 Mar; 596():22-28. PubMed ID: 35108650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the role of λ6 immunoglobulin light chain dimerization in amyloid formation.
    Wolwertz ML; Nguyen PT; Quittot N; Bourgault S
    Biochim Biophys Acta; 2016 Apr; 1864(4):409-18. PubMed ID: 26802902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of amyloid fibers by monomeric light chain variable domains.
    Brumshtein B; Esswein SR; Landau M; Ryan CM; Whitelegge JP; Phillips ML; Cascio D; Sawaya MR; Eisenberg DS
    J Biol Chem; 2014 Oct; 289(40):27513-25. PubMed ID: 25138218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
    Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
    Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent mechanisms favor fast amyloid formation in two lambda 6a Ig light chain mutants.
    Valdés-García G; Millán-Pacheco C; Pastor N
    Biopolymers; 2017 Aug; 107(8):. PubMed ID: 28509352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.
    Perfetti V; Casarini S; Palladini G; Vignarelli MC; Klersy C; Diegoli M; Ascari E; Merlini G
    Blood; 2002 Aug; 100(3):948-53. PubMed ID: 12130507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
    Kimura K; Tsukamoto S; Miyazaki K; Kawajiri-Manako C; Ishii A; Rahmutulla B; Fukuyo M; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Matsusaka K; Sanada M; Yokote K; Kaneda A; Ishida T; Suzuki K; Nakaseko C; Sakaida E
    Exp Hematol; 2021 Sep; 101-102():34-41.e4. PubMed ID: 34411686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity.
    Wall J; Schell M; Murphy C; Hrncic R; Stevens FJ; Solomon A
    Biochemistry; 1999 Oct; 38(42):14101-8. PubMed ID: 10529258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
    Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
    PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AL amyloidosis with a localized B cell neoplasia.
    Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
    Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.